<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Title" content="">
<meta name="Keywords" content="">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style id="owaParaStyle"><!--
/* Font Definitions */
@font-face
        {font-family:"MS 明朝";}
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Tahoma;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:12.0pt;
        font-family:"Times New Roman";}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
p
        {mso-style-priority:99;
        margin:0in;
        margin-bottom:.0001pt;
        font-size:12.0pt;
        font-family:"Times New Roman";}
p.msochpdefault, li.msochpdefault, div.msochpdefault
        {mso-style-name:msochpdefault;
        margin:0in;
        margin-bottom:.0001pt;
        font-size:10.0pt;
        font-family:"Times New Roman";}
span.emailstyle20
        {mso-style-name:emailstyle20;
        font-family:Calibri;
        color:windowtext;}
span.msoins
        {mso-style-name:msoins;
        color:teal;
        text-decoration:underline;}
span.emailstyle22
        {mso-style-name:emailstyle22;
        font-family:Calibri;
        color:windowtext;}
span.EmailStyle23
        {mso-style-type:personal-reply;
        font-family:Calibri;
        color:windowtext;}
span.msoIns
        {mso-style-type:export-only;
        mso-style-name:"";
        text-decoration:underline;
        color:teal;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-size:10.0pt;}
@page WordSection1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
        {page:WordSection1;}
--></style>
</head>
<body bgcolor="white" lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:Calibri">Please see the information below about the Advanced Undergraduate Seminar 7.346: &quot;Hunting for the Genes that Cause Brain Disorders and Aging.&quot; This class is still open.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:Calibri">Thanks,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:Calibri">Crystal<o:p></o:p></span></p>
<div>
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:Helvetica;color:black">---------------</span><span style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:Helvetica;color:black">Crystal Boateng (Pronouns: they/them/themselves)</span><span style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:Helvetica;color:black">Biology Education Office 68-120<br>
Massachusetts Institute of Technology<br>
31 Ames Street,&nbsp;Cambridge, MA 02139</span><span style="color:black"><o:p></o:p></span></p>
</div>
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:Helvetica;color:black">ph: 617-252-1783 /&nbsp;f: 617-258-9329&nbsp;/ e:&nbsp;</span><span style="color:black"><a href="mailto:cboateng@mit.edu"><span style="font-size:9.0pt;font-family:Helvetica">cboateng@mit.edu</span></a></span><span style="font-size:11.0pt;font-family:Calibri"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:Calibri"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:Calibri"><o:p>&nbsp;</o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:Calibri"><o:p>&nbsp;</o:p></span></p>
<div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span style="font-family:Calibri;color:black">From: </span>
</b><span style="font-family:Calibri;color:black">Zara Herskovits &lt;aherskov@mit.edu&gt;<o:p></o:p></span></p>
</div>
<div>
<div>
<div>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:Tahoma;color:black"><br>
<strong><span style="font-family:Tahoma">Biology 7.346&nbsp; &quot;Hunting for the Genes that Cause Brain Disorders and Aging&quot;
</span></strong></span><span style="color:black"><o:p></o:p></span></p>
</div>
<div>
<p><span style="font-size:10.0pt;font-family:Tahoma;color:black">Neurological diseases are one of the most important medical challenges facing society today.&nbsp; One in four people will have an episode of major depression in their lifetimes, and almost half of
 people over 85 years old have Alzheimer's disease.&nbsp;&nbsp; This course will walk through how the first genes for monogenic neurodegenerative disorders, such as amyotrophic lateral sclerosis and Huntington's disease, were discovered using classical approaches.&nbsp; We
 will continue through current studies, from which the genetic architecture of complex diseases such as schizophrenia are just being uncovered.&nbsp; We will discuss how an individual's risk of developing a disease can be assessed from small genetic changes in nucleotide
 sequence and on larger structural variations that affect entire regions of a chromosome.&nbsp; We will read papers from the primary scinetific literature to understand how genetics is informing the treatment of patients with neurological disorders.&nbsp; Genomic anlaysis
 has spurred the development of new treatment strategies, such as antisense oligonucleotide therapies for diseases such as spinal muscular atrophy and amyotrophic lateral sclerosis.&nbsp; This course will combine discussions of primary scientific literature with
 hands-on data analysis and small group presentations. We will take a field trip to a local pharmaceutical company to learn about how new treatments for these neurological conditions are being developed.<o:p></o:p></span></p>
<p><span style="font-size:10.0pt;font-family:Tahoma;color:black"><o:p>&nbsp;</o:p></span></p>
<p><span style="font-size:10.0pt;font-family:Tahoma;color:black"><a href="https://stellar.mit.edu/S/course/7/fa16/7.346/" target="_blank">https://stellar.mit.edu/S/course/7/fa16/7.346/</a>&nbsp;&nbsp;<o:p></o:p></span></p>
<p><span style="font-size:10.0pt;font-family:Tahoma;color:black"><o:p>&nbsp;</o:p></span></p>
<p><strong><span style="font-size:10.0pt;font-family:Tahoma;color:black">IF YOU HAVE MISSED THE FIRST CLASS, BUT ARE STILL INTERESTED IN TAKING THIS COURSE, &nbsp;PLEASE EMAIL THE INSTRUCTORS (</span></strong><span style="font-size:10.0pt;font-family:Tahoma;color:black">
<a href="mailto:GLORIOSO@MIT.EDU" target="_blank"><strong><span style="font-family:Tahoma">GLORIOSO@MIT.EDU</span></strong>
</a><strong><span style="font-family:Tahoma">OR</span></strong> <a href="mailto:AHERSKOV@MIT.EDU" target="_blank">
<strong><span style="font-family:Tahoma">AHERSKOV@MIT.EDU</span></strong> </a><strong><span style="font-family:Tahoma">) WITH YOUR PREFERENCES ABOUT MEETING DAY AND TIME AS SOON AS&nbsp;POSSIBLE.&nbsp; REGISTRATION IS STILL OPEN. THANK YOU!</span></strong><o:p></o:p></span></p>
</div>
</div>
</div>
</div>
</div>
</body>
</html>